CH610894A5 - - Google Patents

Info

Publication number
CH610894A5
CH610894A5 CH592175A CH592175A CH610894A5 CH 610894 A5 CH610894 A5 CH 610894A5 CH 592175 A CH592175 A CH 592175A CH 592175 A CH592175 A CH 592175A CH 610894 A5 CH610894 A5 CH 610894A5
Authority
CH
Switzerland
Application number
CH592175A
Inventor
Bernard Joseph Mcloughlin
Allen John Guildford
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of CH610894A5 publication Critical patent/CH610894A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/04—Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/6533—Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH592175A 1974-05-07 1975-05-07 CH610894A5 (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2001374A GB1452701A (en) 1974-05-07 1974-05-07 Morpholine derivatives
JP2495676A JPS52139074A (en) 1974-05-07 1976-03-08 Morpholine derivative and mental version drug composition containing same

Publications (1)

Publication Number Publication Date
CH610894A5 true CH610894A5 (xx) 1979-05-15

Family

ID=26254367

Family Applications (2)

Application Number Title Priority Date Filing Date
CH592175A CH610894A5 (xx) 1974-05-07 1975-05-07
CH22779A CH634569A5 (de) 1974-05-07 1979-01-10 Verfahren zur herstellung von morpholinderivaten.

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH22779A CH634569A5 (de) 1974-05-07 1979-01-10 Verfahren zur herstellung von morpholinderivaten.

Country Status (20)

Country Link
US (1) US4010266A (xx)
JP (2) JPS50154273A (xx)
AR (1) AR209436A1 (xx)
AT (1) AT344188B (xx)
BE (1) BE828822A (xx)
CA (1) CA1067075A (xx)
CH (2) CH610894A5 (xx)
DD (1) DD121641A5 (xx)
DE (1) DE2519101A1 (xx)
DK (1) DK198675A (xx)
FI (1) FI751344A (xx)
FR (1) FR2269953B1 (xx)
GB (1) GB1452701A (xx)
HK (1) HK5580A (xx)
IN (1) IN141021B (xx)
KE (1) KE3021A (xx)
LU (1) LU72408A1 (xx)
NL (1) NL7505140A (xx)
SE (1) SE425312B (xx)
ZA (1) ZA752388B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4088814A (en) * 1974-05-07 1978-05-09 Imperial Chemical Industries Limited Morpholine derivatives
JPS5266991U (xx) * 1975-11-13 1977-05-18
DE2731668A1 (de) * 1976-07-14 1978-01-19 Ici Ltd Appetitzuegler
IE50355B1 (en) * 1979-10-20 1986-04-02 Wyeth John & Brother Ltd Morpholine derivatives
AU3364493A (en) * 1992-01-28 1993-09-01 Smithkline Beecham Plc Compounds as calcium channel antagonists
US6048859A (en) 1992-06-29 2000-04-11 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
US5719147A (en) * 1992-06-29 1998-02-17 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
US5637699A (en) * 1992-06-29 1997-06-10 Merck & Co., Inc. Process for preparing morpholine tachykinin receptor antagonists
TW385308B (en) * 1994-03-04 2000-03-21 Merck & Co Inc Prodrugs of morpholine tachykinin receptor antagonists
US6207662B1 (en) 1996-08-23 2001-03-27 Neurosearch A/S Disubstituted morpholine, oxazepine or thiazepine derivatives, their preparation and their use as dopamine D4 receptor antagonists
JP2004509103A (ja) 2000-09-11 2004-03-25 セプレイコー　インコーポレイテッド モノアミン受容体及び輸送体のリガンドならびにその使用方法
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2255077A (en) * 1938-03-21 1941-09-09 Du Pont Film Mfg Corp Filter dyes for color photography

Also Published As

Publication number Publication date
AT344188B (de) 1978-07-10
GB1452701A (en) 1976-10-13
SE7505237L (sv) 1975-11-10
SE425312B (sv) 1982-09-20
FR2269953B1 (xx) 1978-10-06
NL7505140A (nl) 1975-11-11
CA1067075A (en) 1979-11-27
HK5580A (en) 1980-02-29
AR209436A1 (es) 1977-04-29
JPS50154273A (xx) 1975-12-12
DE2519101A1 (de) 1975-11-20
BE828822A (fr) 1975-11-07
KE3021A (en) 1980-03-14
IN141021B (xx) 1977-01-08
ZA752388B (en) 1976-03-31
LU72408A1 (xx) 1976-11-11
FR2269953A1 (xx) 1975-12-05
FI751344A (xx) 1975-11-08
DD121641A5 (xx) 1976-08-12
US4010266A (en) 1977-03-01
DK198675A (da) 1975-11-08
CH634569A5 (de) 1983-02-15
AU8021575A (en) 1976-10-21
JPS52139074A (en) 1977-11-19
ATA341575A (de) 1977-11-15

Similar Documents

Publication Publication Date Title
FR2270418B1 (xx)
FR2315376B1 (xx)
FR2291466B1 (xx)
FR2269953B1 (xx)
FR2279794B1 (xx)
FR2293916B1 (xx)
FR2264131A1 (xx)
FI752145A (xx)
FR2291779B3 (xx)
FR2259387B1 (xx)
FR2262083B1 (xx)
AU495930B2 (xx)
FR2288807B3 (xx)
FR2279403B1 (xx)
CS174550B1 (xx)
JPS50102034A (xx)
AU480208A (xx)
BG20446A1 (xx)
BG19987A1 (xx)
AU480471A (xx)
BG20440A1 (xx)
BG21307A1 (xx)
CH562521A5 (xx)
AU480247A (xx)
CH563933A5 (xx)

Legal Events

Date Code Title Description
PL Patent ceased